By Claudia Mendoza
Jan 11, 2021
Check-in with us every morning as we kick off 90 minutes of Non-Stop ’90s at 8:00 am! @Totally939Miami! - #MackInTheMorning @MACKONTHERADIO & @ClaudiaMonair, who s filling in for @iAmLettyB.
Miami-Dade County Public Schools and the University of Miami Health System are working together to provide FREE COVID-19 testing to students in schools across Miami-Dade County. The effort will be a month-long tour for UM s health system Pediatric Mobile Unit. It started last week at Coral Reef Senior High School and continues today at J.C. Bermudez Doral Senior High, 5005 NW 112th Ave.
This service is for parents to take their children to one of these selected schools to get tested from 3 p.m. to 5 p.m. But there s only one catch. It s only available for children ages 4 to 18, identification is not required, but parents will need to accompany the child.
This is according to the
University of Miami, which is conducting research into the new coronavirus vaccines flooding the United States to ascertain whether or not they can cause infertility and whether they have any other damaging effects.
https://twitter.com/michellemalkin/status/1342189503016923136
The study is being led by Dr. Ranjith Ramasamy, a reproductive urologist working for the
University of Miami Health System and an expert in male infertility, andrology, sexual dysfunction and hypogonadism. He led an earlier study that found that the coronavirus was present in the testicles of men with COVID-19 for up to six months after the initial infection.
UC-MSC infusions reduce risk of death, quicken recovery time in severe COVID-19 cases
Dr. Camilo Ricordi, director of the Diabetes Research Institute (DRI) and Cell Transplant Center at the University of Miami Miller School of Medicine, and his team of international collaborators are reporting the results of a groundbreaking randomized controlled trial showing umbilical cord-derived mesenchymal stem cell (UC-MSC) infusions safely reduce risk of death and quicken time to recovery for the most severe COVID-19 patients. Dr. Ricordi s peer-reviewed paper has just been published in
STEM CELLS Translational Medicine (SCTM) January 2021.
The clinical trial, authorized by the FDA last April, was initiated by The Cure Alliance, a 501(c)(3) non-profit organization of research scientists founded ten years ago by Dr. Ricordi for scientists around the world to share knowledge and accelerate cures of all diseases.